Reckitt Benckiser Group (LON:RB) had its price target decreased by equities researchers at Royal Bank of Canada from GBX 5,900 ($77.09) to GBX 5,300 ($69.25) in a research note issued on Wednesday, ThisIsMoney.Co.Uk reports. The firm presently has an “underperform” rating on the stock. Royal Bank of Canada’s target price would indicate a potential downside of 8.83% from the stock’s current price.
A number of other research analysts also recently weighed in on RB. HSBC set a GBX 7,700 ($100.61) price objective on shares of Reckitt Benckiser Group and gave the stock a “buy” rating in a research report on Thursday, October 10th. Berenberg Bank began coverage on shares of Reckitt Benckiser Group in a research report on Wednesday, October 16th. They issued a “buy” rating and a GBX 7,420 ($96.96) price objective for the company. UBS Group set a GBX 6,500 ($84.93) price objective on shares of Reckitt Benckiser Group and gave the stock a “neutral” rating in a research report on Tuesday. Jefferies Financial Group set a GBX 5,550 ($72.52) price objective on shares of Reckitt Benckiser Group and gave the stock a “sell” rating in a research report on Tuesday. Finally, Sanford C. Bernstein set a GBX 7,600 ($99.31) price objective on shares of Reckitt Benckiser Group and gave the stock a “buy” rating in a research report on Friday, October 18th. Four equities research analysts have rated the stock with a sell rating, three have given a hold rating and ten have issued a buy rating to the stock. Reckitt Benckiser Group currently has an average rating of “Hold” and an average price target of GBX 6,977.65 ($91.18).
Shares of Reckitt Benckiser Group stock opened at GBX 5,813 ($75.96) on Wednesday. The firm has a 50-day simple moving average of GBX 6,251.10 and a two-hundred day simple moving average of GBX 6,264.74. The company has a market cap of $41.08 billion and a P/E ratio of 29.18. Reckitt Benckiser Group has a fifty-two week low of GBX 5,559 ($72.64) and a fifty-two week high of GBX 6,862 ($89.66). The company has a debt-to-equity ratio of 85.08, a quick ratio of 0.43 and a current ratio of 0.59.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Story: How Do You Calculate Return on Investment (ROI)?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.